EU4Health
EU4Health funds research and innovation projects to strengthen health systems, boost crisis preparedness, and advance disease prevention and therapeutics across the EU post-COVID-19.
Funder: European Commission
Due Dates: May 12, 2026 (SoHO regulation training) | July 3, 2026 (Therapeutics for infectious diseases) | August 24, 2026 (Filovirus vaccine reserve) | September 3, 2026 (API stockpiling) | September 10, 2026 (PPE capacity reservation)
Funding Amounts: Programme budget: €4.4–€5.75 billion (2021–2027); individual call amounts vary by topic and action.
Summary: Large-scale EU programme supporting projects to strengthen health systems, improve public health, and boost resilience across Europe post-COVID-19.
Key Information: Multiple calls open annually; eligibility extends to EU/EEA and associated countries.
Description
EU4Health is the European Union’s flagship health funding programme for 2021–2027, created in response to the COVID-19 pandemic and designed to reinforce crisis preparedness, strengthen health systems, and address pressing health challenges across the EU and associated countries. Managed by the European Health and Digital Executive Agency (HaDEA), EU4Health funds projects, tenders, and initiatives that improve health outcomes, foster innovation, and support health system resilience.
The programme covers a broad range of priorities, including:
- Health promotion and disease prevention (notably cancer and mental health)
- Crisis preparedness and response to cross-border health threats
- Ensuring access to medicinal products, medical devices, and crisis-relevant supplies
- Digital transformation and reinforcement of health systems
Funding is awarded through competitive calls for proposals and tenders, published throughout the year.
